|
DDX52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.491880E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.453500E-02 |
| Normal-vs-Stage2 |
1.950810E-01 |
| Normal-vs-Stage3 |
3.574400E-01 |
| Normal-vs-Stage4 |
2.061800E-01 |
| Stage1-vs-Stage2 |
4.927600E-01 |
| Stage1-vs-Stage3 |
9.154400E-01 |
| Stage1-vs-Stage4 |
3.864200E-01 |
| Stage2-vs-Stage3 |
4.677800E-01 |
| Stage2-vs-Stage4 |
9.162000E-01 |
| Stage3-vs-Stage4 |
4.098600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.869750E-02 |
| Normal-vs-AfricanAmerican |
3.429400E-01 |
| Normal-vs-Asian |
4.418600E-01 |
| Caucasian-vs-AfricanAmerican |
3.968200E-01 |
| Caucasian-vs-Asian |
8.051000E-01 |
| AfricanAmerican-vs-Asian |
5.774200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.002570E-01 |
| Normal-vs-Female |
2.056300E-03 |
| Male-vs-Female |
2.216000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.917400E-01 |
| Normal-vs-Extreme_Weight |
5.154400E-01 |
| Normal-vs-Obese |
6.175800E-02 |
| Normal-vs-Extreme_Obese |
5.996200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.207800E-01 |
| Normal_Weight-vs-Obese |
5.304000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.219200E-01 |
| Extreme_Weight-vs-Obese |
2.388200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.499600E-01 |
| Obese-vs-Extreme_Obese |
7.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.175500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.544310E-03 |
| Normal-vs-Age(61-80Yrs) |
4.797000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.403800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.071900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.963300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.021200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.755700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.280460E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.634600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.299800E-03 |
| Normal-VS-Type2 PRCC |
6.790800E-01 |
| Normal-VS-KIRP CIMP |
2.756100E-02 |
| Normal-VS-Unclassified PRCC |
9.418000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.980200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.391800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.603600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.743060E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.944580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.776200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.837800E-01 |
| Normal-vs-N1 |
1.529920E-02 |
| Normal-vs-N2 |
9.890200E-01 |
| N0-vs-N1 |
1.441970E-02 |
| N0-vs-N2 |
9.686600E-01 |
| N1-vs-N2 |
2.941400E-01 |
|
|
